Virtual ISPOR-FDA Summit 2020

Tuesday, September 29

Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond

Patient-preference information (PPI) is increasingly being used in regulatory decision making for medical devices. This virtual Summit will provide a forum to engage all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.

The virtual Summit is jointly sponsored by ISPOR—the professional society for health economics and outcomes research—and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH).

Objectives for discussion are:

  • To provide a forum for engaging all stakeholders to discuss and explore the role, challenges, and opportunities of using PPI.
  • To identify possible barriers and highlight the opportunities for integrating PPI throughout the product lifecycle.
  • To clarify the value of including PPI in regulatory, reimbursement, and patient-provider decision-making processes.

Full program descriptions and schedule are available here.

Registration for the Virtual ISPOR-FDA Summit 2020 is complimentary. However, registrants for the previously scheduled event on March 31, are requested to re-register for the new, completely virtual event now scheduled for September 29.

Register here: https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-fda-summit-2020/about/registration-information?utm_medium=email&utm_source=registration&utm_campaign=virtual+fda+summit+2020&_zs=pM2lb&_zl=Kx4C2

Follow this blog